Outcomes of hematologic malignancy patients with SARS-CoV-2 breakthrough infections after tixagevimab-cilgavimab during community transmission of monoclonal antibody resistant variants

被引：3
|
作者：
Kamboj, Mini [1 ,2 ,3 ,5 ]
Laracy, Justin C. [1 ,2 ,3 ,5 ]
Usiak, Shauna [1 ]
Babady, N. Esther [2 ,4 ]
Yan, Judy [1 ]
Seo, Susan K. [2 ,3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Infect Control, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY USA
[3] Weill Cornell Med Coll, Dept Med, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, Clin Microbiol Serv, New York, NY USA
[5] 1275 York Ave, New York, NY 10065 USA
来源：
JOURNAL OF INFECTION | 2023年 / 87卷 / 03期
关键词：
D O I：
10.1016/j.jinf.2023.06.024
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：282 / 285
页数：4
相关论文
共 50 条
  • [31] Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination
    Butt, Adeel A.
    Nafady-Hego, Hanaa
    Chemaitelly, Hiam
    Abou-Samra, Abdul-Badi
    Al Khal, Abdullatif
    V. Coyle, Peter
    Al Kanaani, Zeina
    Kaleeckal, Anvar H.
    Latif, Ali Nizar
    Al Masalmani, Yousuf
    Bertollini, Roberto
    Abu Raddad, Laith J.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 110 : 353 - 358
  • [32] Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study
    Assanto, Giovanni Manfredi
    Totaro, Matteo
    Poggiali, Rebecca
    Delli Paoli, Adele
    Annechini, Giorgia
    D'Elia, Gianna Maria
    Aji, Francesco
    Petrucci, Luigi
    Fazio, Francesca
    Del Giudice, Ilaria
    Martelli, Maurizio
    Micozzi, Alessandra
    Gentile, Giuseppe
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2023, 15 (01)
  • [33] Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer
    Mair, Maximilian J.
    Mitterer, Manfred
    Gattinger, Pia
    Berger, Julia M.
    Valenta, Rudolf
    Fong, Dominic
    Preusser, Matthias
    JAMA ONCOLOGY, 2022, 8 (11) : 1694 - 1696
  • [34] A rapid decline in the anti-receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab-cilgavimab administration
    Benotmane, Ilies
    Velay, Aurelie
    Vargas, Gabriela-Gautier
    Olagne, Jerome
    Cognard, Noelle
    Heibel, Francoise
    Braun-Parvez, Laura
    Martzloff, Jonas
    Perrin, Peggy
    Pszczolinsk, Romain
    Moulin, Bruno
    Fafi-Kremer, Samira
    Caillard, Sophie
    KIDNEY INTERNATIONAL, 2022, 102 (05) : 1188 - +
  • [35] Use and Outcomes of SARS-COV-2 Monoclonal Antibody Therapy in Patients with Primary Immunodeficiency
    Monahan, Rose
    Tang, Monica
    Pham, Michele
    JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (SUPPL 1) : S88 - S88
  • [36] Real-World Experience of Tixagevimab and Cilgavimab (Evusheld) as SARS-CoV-2 Prophylaxis in Multiple Sclerosis Patients undergoing anti-CD20 monoclonal antibody Therapies.
    Somovilla, Alba
    Reguero, Laura
    Aguirre, Clara
    Diaz Perez, Carolina
    Del Rio Munoz, Beatriz
    Ramon Villagrasa, Jose
    Vivancos, Jose
    Meca, Virginia
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 648 - 649
  • [37] Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies
    Ryutaro Taenaka
    Teppei Obara
    Kentaro Kohno
    Kenichi Aoki
    Ryosuke Ogawa
    Annals of Hematology, 2022, 101 : 1877 - 1878
  • [38] Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients-A Tailored Approach Based on SARS-CoV-2 Vaccine Response
    Braitsch, Krischan
    Jeske, Samuel D.
    Stroh, Jacob
    Hefter, Maike
    Platen, Louise
    Bachmann, Quirin
    Renders, Lutz
    Protzer, Ulrike
    Goetze, Katharina S.
    Herhaus, Peter
    Verbeek, Mareike
    Spinner, Christoph D.
    Bassermann, Florian
    Hoegner, Marion
    Haller, Bernhard
    Schneider, Jochen
    Heider, Michael
    VACCINES, 2024, 12 (08)
  • [39] Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies
    Taenaka, Ryutaro
    Obara, Teppei
    Kohno, Kentaro
    Aoki, Kenichi
    Ogawa, Ryosuke
    ANNALS OF HEMATOLOGY, 2022, 101 (08) : 1877 - 1878
  • [40] Clinical Outcomes of SARS-CoV-2 Breakthrough Infections in Liver Transplant Recipients during the Omicron Wave
    Herting, Anna
    Jahnke-Triankowski, Jacqueline
    Harberts, Aenne
    Schaub, Golda M.
    Luetgehetmann, Marc
    Ruether, Darius F.
    Fischer, Lutz
    Addo, Marylyn M.
    Lohse, Ansgar W.
    zur Wiesch, Julian Schulze
    Sterneck, Martina
    VIRUSES-BASEL, 2023, 15 (02):
12345